No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.
Andrea CarugnoF RaponiA G LocatelliP VezzoliD M GambiniM Di MercurioE Robustelli TestP SenaPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)